Sergey Bolevich
Overview
Explore the profile of Sergey Bolevich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stojkovic D, Zivkovic J, Bolevich S, Bolevich S, Zengin G, Gasic U, et al.
Plants (Basel)
. 2025 Feb;
14(4).
PMID: 40006842
(L.) Ach. (Parmeliaceae), an edible lichen commonly known as oakmoss, was traditionally used by Egyptians to make bread. In this study, the ethyl-acetate (EtOAc) extract of was investigated for its...
2.
Muric M, Srejovic I, Novakovic J, Zivkovic V, Jovic J, Sretenovic J, et al.
Cardiovasc Drugs Ther
. 2025 Feb;
PMID: 39913081
Purpose: The idea behind this study was to assess the effects of empagliflozin and sacubitril/valsartan and their combination on isoproterenol-induced heart failure (HF) and underlying molecular mechanisms. Methods: HF was...
3.
Savic M, Dragasevic N, Sretenovic J, Mihajlovic K, Andjic M, Djordjevic K, et al.
Mol Cell Biochem
. 2025 Jan;
PMID: 39800798
As several decades of research have shown the cardioprotective effects of angiotensin-converting enzyme (ACE) inhibitors alone or in combination with diuretics, we were interested in investigating the effects of subchronic...
4.
Orlova A, Malygin Y, Gofman A, Sotulenko S, Gandalian V, Kartashov I, et al.
Life (Basel)
. 2025 Jan;
14(12.
PMID: 39768371
Objective: Amyotrophic lateral sclerosis is a neurodegenerative disease with high rates of disability and mortality. Non-invasive ventilation (NIV) is an effective method of treating patients, increasing life expectancy, but currently,...
5.
Mihajlovic D, dukanovic D, Gajic Bojic M, Jovicic S, Mandic-Kovacevic N, Uletilovic S, et al.
Biomolecules
. 2024 Oct;
14(10).
PMID: 39456147
Patients suffering from cholelithiasis have an increased risk of developing cardiovascular complications, particularly ischemic myocardial disease. Ursodeoxycholic acid (UDCA), already used in clinical practice for the treatment of cholelithiasis and...
6.
Dimitrov V, Mikerova M, Reshetnikov V, Mikhailovsky V, Raicevic S, Bolevich S, et al.
Pathophysiology
. 2024 Sep;
31(3):502-513.
PMID: 39311311
: The pathophysiological mechanism underlying pregnancy complications is not entirely known. Although it is currently impossible to predict the occurrence of redox imbalance, it is possible to identify women with...
7.
Ordashev K, Milojevic Samanovic A, Omarov I, Zivkovic V, Nikolic Turnic T, Novakovic J, et al.
Arch Oral Biol
. 2024 Sep;
169:106089.
PMID: 39255649
Objective: To evaluate the possible effects of apical periodontitis (AP) on cardiac function, structure, and oxidative stress (OS) in rats with diabetes mellitus type 2 (T2DM). Design: Forty-eight (Wistar albino,...
8.
Rudic T, Stojanovic A, Sobot N, Novakovic J, Bolevich S, Bolevich S, et al.
Mol Cell Biochem
. 2024 Aug;
480(3):1747-1762.
PMID: 39187740
Cardiovascular diseases remains leading cause of death and disabilities. Coronary artery occlusion and consequent ischemia leads to acute myocardial infarction, but restoration of blood flow, paradoxically, provokes further myocardial damage...
9.
Bradic J, Petrovic A, Kocovic A, Mitrovic S, Jakovljevic V, Lazarevic N, et al.
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39125920
This study aimed to prepare, characterize and assess the antioxidant activity of yellow bedstraw extracts (YBEs), focusing on identifying extracts with high antioxidant capacity. The selected extract was loaded into...
10.
Nikolic M, Srejovic I, Jovic J, Sretenovic J, Jeremic J, Cekerevac I, et al.
Rev Cardiovasc Med
. 2024 Jul;
23(7):238.
PMID: 39076908
As the ultimate pathophysiological event, heart failure (HF) may arise from various cardiovascular (CV) conditions, including sustained pressure/volume overload of the left ventricle, myocardial infarction or ischemia, and cardiomyopathies. Sacubitril/valsartan...